POINT BIOPHARMA GLOBAL INC (PNT) Stock Analyst Earnings Estimates
NASDAQ:PNT - Nasdaq - US7305411099 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 226.6M | 20.448M -90.98% | 35.182M 72.06% | 228.64M 549.88% | 146.86M -35.77% | 365.44M 148.84% | 649.09M 77.62% | 476.94M -26.52% | 569.65M 19.44% | |||
| EBITDA YoY % growth | N/A | N/A | 126.9M | -125.24M -198.69% | -142.41M -13.71% | 63.63M 144.68% | -138.37M -317.46% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -13.1M | -45.5M -247.33% | 125.5M 375.82% | -120.451M -195.98% | -108.241M 10.14% | -15.595M 85.59% | -85.727M -449.70% | 54.341M 163.39% | 205.09M 277.41% | 145.62M -29.00% | 217.78M 49.55% | |
| Operating Margin | N/A | N/A | 55.38% | -589.06% | -307.66% | -6.82% | -58.37% | 14.87% | 31.60% | 30.53% | 38.23% | |
| EPS YoY % growth | N/A | N/A | N/A -52.78% | -0.89 9.21% | -1.04 -15.99% | 0.56 153.87% | -0.69 -223.67% | 0.80 215.25% | 1.87 134.50% | 1.55 -17.15% | 1.92 24.51% |
All data in USD
| Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.26 1.39% | -0.29 -81.80% | -0.30 -23.72% | -0.22 4.27% | -0.11 59.78% | -0.37 -28.47% | -0.37 -25.85% | -0.37 -69.72% | 2.08 2,080.77% | -0.35 5.41% | -0.33 10.81% | -0.31 16.22% |
| Revenue Q2Q % growth | 2.289M -98.99% | 1.136M -88.04% | 1.136M -76.82% | 13.13M 368.93% | 37.37M 1,532.59% | 295.93M 25,950.18% | 3.578M 214.96% | 3.578M -72.75% | 284.08M 660.18% | 2.562M -99.13% | 5.486M 53.33% | 10.67M 198.21% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -33.46M -117.48% | -33.498M -48.88% | -34.447M -9.35% | -22.077M 25.41% | 1.214M 103.63% | -33.154M 1.03% | -33.154M 3.75% | -34.164M -54.75% | -34.164M -2,914.19% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | -0.23 11.54% | -0.30 | 0.07 | 24.55% |
| Q2 2023 Q2Q % growth | -0.24 11.11% | -0.30 | 0.06 | 19.08% |
| Q1 2023 Q2Q % growth | -0.16 11.11% | -0.32 | 0.16 | 49.55% |
| Q4 2022 Q2Q % growth | -65.53% | -0.26 | % | |
| Q3 2022 Q2Q % growth | -0.26 -36.84% | -0.29 | 0.03 | 8.79% |
| Q2 2022 Q2Q % growth | -0.27 -80.00% | -0.22 | -0.05 | -20.42% |
| Q1 2022 Q2Q % growth | -0.18 | -0.21 | 0.03 | 15.13% |
| Q4 2021 Q2Q % growth | -0.16 | -0.24 | 0.08 | 32.59% |
| Q3 2021 Q2Q % growth | -0.19 | -0.19 | 0.00 | -0.78% |
| Q2 2021 Q2Q % growth | -0.15 | -0.11 | -0.04 | -35.01% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | 2.8M | 897.779K | 1.902M | 211.88% |
| Q2 2023 Q2Q % growth | 4.9M | 953.884K | 3.946M | 413.69% |
| Q4 2022 Q2Q % growth | 226.6M | 26.26M | 200.34M | 762.91% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 14.94% | 0% | 12.19% |
| Revenue | 0% | 83.86% | 0% | 25.31% |